XARELTO RIVAROXABAN Trademark

Trademark Overview

On Thursday, June 4, 2009, a trademark application was filed for XARELTO RIVAROXABAN with the United States Patent and Trademark Office. The USPTO has given the XARELTO RIVAROXABAN trademark a serial number of 77752447. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, July 28, 2022. This trademark is owned by Bayer Aktiengesellschaft. The XARELTO RIVAROXABAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of cardiovascular diseases, thrombosis, stroke and pulmonary embolism
xarelto rivaroxaban

General Information

Serial Number77752447
Word MarkXARELTO RIVAROXABAN
Filing DateThursday, June 4, 2009
Status800 - REGISTERED AND RENEWED
Status DateThursday, July 28, 2022
Registration Number4102740
Registration DateTuesday, February 21, 2012
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 27, 2009

Trademark Statements

Description of MarkThe mark consists of a design of four-sided shapes in a triangular pattern with the shapes from left to right in gray and purple with one pink square in the middle, all to the left of the stylized wording "XARELTO" in purple and "RIVAROXABAN" in gray.
Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of cardiovascular diseases, thrombosis, stroke and pulmonary embolism
Indication of Colors claimedThe color(s) purple, pink and grey is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"RIVAROXABAN"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 8, 2009
Primary Code005
First Use Anywhere DateSaturday, July 2, 2011
First Use In Commerce DateSaturday, July 2, 2011

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
Address51373 Leverkusen
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
Address51373 Leverkusen
DE

Trademark Events

Event DateEvent Description
Friday, July 29, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, July 28, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, July 28, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, July 5, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 26, 2022TEAS SECTION 8 & 9 RECEIVED
Sunday, February 21, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 16, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, February 18, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, February 17, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, February 17, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 7, 2018TEAS SECTION 8 & 15 RECEIVED
Tuesday, February 21, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 21, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, January 19, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 18, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 17, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 17, 2012STATEMENT OF USE PROCESSING COMPLETE
Friday, January 13, 2012USE AMENDMENT FILED
Tuesday, January 17, 2012SOU EXTENSION 4 GRANTED
Friday, January 13, 2012SOU EXTENSION 4 FILED
Friday, January 13, 2012TEAS EXTENSION RECEIVED
Friday, January 13, 2012TEAS STATEMENT OF USE RECEIVED
Friday, July 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 13, 2011SOU EXTENSION 3 GRANTED
Wednesday, July 13, 2011SOU EXTENSION 3 FILED
Wednesday, July 13, 2011TEAS EXTENSION RECEIVED
Thursday, January 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 19, 2011SOU EXTENSION 2 GRANTED
Monday, January 17, 2011SOU EXTENSION 2 FILED
Monday, January 17, 2011TEAS EXTENSION RECEIVED
Saturday, July 31, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 30, 2010SOU EXTENSION 1 GRANTED
Tuesday, June 29, 2010SOU EXTENSION 1 FILED
Friday, July 30, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 29, 2010TEAS EXTENSION RECEIVED
Thursday, February 4, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 4, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 19, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2009PUBLISHED FOR OPPOSITION
Monday, September 21, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 21, 2009ASSIGNED TO LIE
Thursday, September 10, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 9, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 9, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 9, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 11, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 11, 2009NON-FINAL ACTION E-MAILED
Thursday, June 11, 2009NON-FINAL ACTION WRITTEN
Thursday, June 11, 2009ASSIGNED TO EXAMINER
Tuesday, June 9, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Monday, June 8, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 8, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

rivaroxaban xarelto thrombosis stroke pulmonary embolism diseases cardiovascular preparations substances prevention treatment